Literature DB >> 28863256

Bezlotoxumab for Preventing Recurrent Clostridium difficile Infections.

Jessica Rounds1, Joe Strain2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28863256

Source DB:  PubMed          Journal:  S D Med        ISSN： 0038-3317


× No keyword cloud information.
  3 in total

Review 1.  Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review.

Authors:  Akshita Gupta; Ashwin N Ananthakrishnan
Journal:  Therap Adv Gastroenterol       Date:  2021-05-30       Impact factor: 4.409

2.  Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa.

Authors:  Cansu Kaya; Isabell Walter; Alaa Alhayek; Roya Shafiei; Gwenaëlle Jézéquel; Anastasia Andreas; Jelena Konstantinović; Esther Schönauer; Asfandyar Sikandar; Jörg Haupenthal; Rolf Müller; Hans Brandstetter; Rolf W Hartmann; Anna K H Hirsch
Journal:  ACS Infect Dis       Date:  2022-04-22       Impact factor: 5.578

Review 3.  The prognostic value of toxin B and binary toxin in Clostridioides difficile infection.

Authors:  Salvador López-Cárdenas; Eva Torres-Martos; Juan Mora-Delgado; Juan Manuel Sánchez-Calvo; Marta Santos-Peña; Ángel Zapata López; María Dolores López-Prieto; Salvador Pérez-Cortés; Juan Carlos Alados
Journal:  Gut Microbes       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.